Replies to post #48042 on MMRGlobal, Inc. (fka MMRF)

[ssc]

Sounds to me like lorsch is realizing how much hard work and how many more years it will take before mmr's products are in demand. His past attempts to inflate the share price with his forward looking statements regarding revenues, patents, verizon, microsoft, etc., have failed miserably and have actually driven the share price lower. He is not up for what it will take to build a real business so now he's looking to bail. Hopefully he'll find a buyer willing to pay more than the current market cap before he throws in the towel completely and leaves shareholders as bagholders. The problem is, to find a buyer requires that you actually have something of value to sell.

It will be very interesting to see if everything he has touted translates into any value.

[EZ2]

Celgene Corporation to Present at Two Upcoming Investor Conferences

05/04 07:30 AM

--------------------------------------------------------------------------------

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (CELG:$71.40,00$-0.57,00-0.79%) announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the Company’s Web site at www.celgene.com. Celgene (CELG:$71.40,00$-0.57,00-0.79%) management will provide an overview of the Company.

Tuesday, May 8, 2012Celgene (CELG:$71.40,00$-0.57,00-0.79%) will present at the Baird 2012 Growth Stock Conference at 12:20 p.m. ET.

Thursday, May 17, 2012Celgene (CELG:$71.40,00$-0.57,00-0.79%) will present at the Bank of America Merrill Lynch 2012 Health Care Conference at 11:40 a.m. ET.


About Celgene (CELG:$71.40,00$-0.57,00-0.79%)

Celgene Corporation (CELG:$71.40,00$-0.57,00-0.79%) , headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at www.celgene.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.



Source: Celgene Corporation (CELG:$71.40,00$-0.57,00-0.79%)